Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Because Wegovy has FDA approval for cardiovascular risk reduction and MASH treatment, many Medicare prescription plans that havent covered Wegovy for weight loss may now cover it for these indications
7 May 2026
Section 503A pharmacies compound on a patient-specific basis after receiving an individual prescription
Over a longer duration, that gap is projected to expand further because Retatrutide had not plateaued at the 48-week mark
December 22, 2022
US$ 27.69
US$ 22.34
US$ 23.44
